Clinical trial performance is increasingly shaped by more than protocol design and patient recruitment. As studies expand across more sites, countries and transaction types, the financial infrastructure behind them has become a critical measure of operational readiness. Yet many sponsors still rely on fragmented systems and manual workflows to manage budgeting, contracting and payments. According to Zahiah “Zee Zee” Gueddar, those disconnected processes are no longer sustainable because they create delays, limit visibility and put study performance at risk.
For sponsors, clinical trial finance is no longer a back-office function. It is a strategic lever for strengthening site relationships, improving forecasting and keeping studies on track. As site expectations evolve, timely payments, transparency and predictability have become essential to building trust and reducing operational friction. Still, many study teams continue to face limited real-time visibility, inconsistent processes and repeated rework across budgeting and forecasting.
Modernization, then, is not simply about efficiency. It is about building a financial operating model that can support faster, more predictable trials at scale. By moving to connected systems, sponsors can improve accuracy, reduce friction and create a more consistent experience for sites. The result is a shift from reactive administration to a more resilient model that supports stronger execution across the clinical trial journey.